Concepts (811)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 243 | 2024 | 11215 | 10.730 |
Why?
|
| Prostatectomy | 73 | 2024 | 1905 | 6.050 |
Why?
|
| Urinary Bladder Neoplasms | 73 | 2023 | 2246 | 5.410 |
Why?
|
| Cystectomy | 49 | 2022 | 687 | 4.800 |
Why?
|
| Prostate-Specific Antigen | 62 | 2024 | 2511 | 3.970 |
Why?
|
| Prostate | 31 | 2024 | 1782 | 2.650 |
Why?
|
| Androgen Antagonists | 27 | 2024 | 1415 | 2.290 |
Why?
|
| Kidney Neoplasms | 34 | 2023 | 4272 | 2.140 |
Why?
|
| Carcinoma, Transitional Cell | 13 | 2021 | 800 | 1.830 |
Why?
|
| Nephrectomy | 25 | 2022 | 1031 | 1.730 |
Why?
|
| Genetic Predisposition to Disease | 46 | 2024 | 17445 | 1.450 |
Why?
|
| Male | 376 | 2024 | 351420 | 1.370 |
Why?
|
| Early Detection of Cancer | 25 | 2024 | 3128 | 1.320 |
Why?
|
| Laparoscopy | 23 | 2023 | 2149 | 1.270 |
Why?
|
| Carcinoma, Renal Cell | 21 | 2023 | 3173 | 1.230 |
Why?
|
| Physicians, Primary Care | 2 | 2024 | 605 | 1.170 |
Why?
|
| Antineoplastic Agents, Hormonal | 12 | 2023 | 1511 | 1.160 |
Why?
|
| Polymorphism, Single Nucleotide | 44 | 2024 | 15386 | 1.150 |
Why?
|
| Neoplasm Staging | 44 | 2022 | 11078 | 1.120 |
Why?
|
| Neoplasms, Hormone-Dependent | 4 | 2018 | 411 | 1.070 |
Why?
|
| Phenylthiohydantoin | 5 | 2021 | 195 | 1.020 |
Why?
|
| Aged | 216 | 2024 | 164383 | 1.010 |
Why?
|
| Robotics | 15 | 2023 | 880 | 1.000 |
Why?
|
| Humans | 414 | 2024 | 746630 | 0.970 |
Why?
|
| Orchiectomy | 6 | 2016 | 469 | 0.910 |
Why?
|
| Postoperative Complications | 43 | 2023 | 15356 | 0.900 |
Why?
|
| Kallikreins | 10 | 2021 | 232 | 0.890 |
Why?
|
| Middle Aged | 201 | 2024 | 214618 | 0.840 |
Why?
|
| Lymph Node Excision | 15 | 2019 | 1278 | 0.830 |
Why?
|
| Biopsy | 12 | 2024 | 6734 | 0.830 |
Why?
|
| DNA Repair-Deficiency Disorders | 1 | 2021 | 30 | 0.790 |
Why?
|
| Urologic Neoplasms | 6 | 2017 | 319 | 0.780 |
Why?
|
| Ureteral Neoplasms | 2 | 2021 | 111 | 0.750 |
Why?
|
| SEER Program | 15 | 2023 | 1512 | 0.730 |
Why?
|
| Germ-Line Mutation | 9 | 2024 | 1815 | 0.730 |
Why?
|
| Brachytherapy | 7 | 2018 | 1242 | 0.720 |
Why?
|
| Neoplasm Recurrence, Local | 20 | 2024 | 9193 | 0.720 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2020 | 38 | 0.710 |
Why?
|
| DNA Repair | 6 | 2023 | 2017 | 0.710 |
Why?
|
| Neoadjuvant Therapy | 14 | 2023 | 2788 | 0.700 |
Why?
|
| Receptors, Androgen | 8 | 2021 | 1066 | 0.690 |
Why?
|
| Healthcare Disparities | 12 | 2024 | 3226 | 0.670 |
Why?
|
| Urology | 5 | 2020 | 410 | 0.670 |
Why?
|
| Watchful Waiting | 6 | 2024 | 502 | 0.660 |
Why?
|
| Tissue Extracts | 4 | 2022 | 141 | 0.620 |
Why?
|
| Multifactorial Inheritance | 7 | 2023 | 1297 | 0.600 |
Why?
|
| United States | 89 | 2024 | 70437 | 0.570 |
Why?
|
| Polymorphism, Genetic | 5 | 2016 | 4276 | 0.560 |
Why?
|
| Poultry | 1 | 2016 | 76 | 0.560 |
Why?
|
| Leuprolide | 6 | 2024 | 319 | 0.550 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2014 | 118 | 0.550 |
Why?
|
| Cancer Vaccines | 2 | 2022 | 1044 | 0.550 |
Why?
|
| Urothelium | 3 | 2017 | 275 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2004 | 433 | 0.550 |
Why?
|
| Urogenital Neoplasms | 2 | 2009 | 135 | 0.540 |
Why?
|
| Disease Management | 3 | 2017 | 2456 | 0.530 |
Why?
|